hepatitis B surface antigen
Showing 1 - 25 of >10,000
Resolved Hepatitis B, CD20 Positive B-cell Lymphoma Trial (Entecavir)
Not yet recruiting
- Resolved Hepatitis B
- CD20 Positive B-cell Lymphoma
- (no location specified)
Jul 10, 2022
Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)
Recruiting
- Chronic Hepatitis B
- continuous treatment
- pulse therapy
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jul 13, 2022
Chronic Hepatitis B Trial in Melbourne (162, Placebo)
Recruiting
- Chronic Hepatitis B
- 162
- Placebo
-
Melbourne, AustraliaNucleus Network Pty Ltd
Jun 5, 2022
Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine
Recruiting
- Hepatitis B
- GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
- +4 more
-
Cambridge, United KingdomGSK Investigational Site
Jan 12, 2023
Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)
Completed
- Chronic Hepatitis B
- PegIFN α- 2b
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jul 11, 2022
Australian Hepatitis and Risk Survey in Prisons
Recruiting
- Hepatitis C
- +2 more
- Point-of-care hepatitis C antibody test
- +5 more
-
Hume, Australian Capital Territory, Australia
- +23 more
Apr 20, 2023
Hepatitis B, Chronic Trial in Worldwide (Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF))
Withdrawn
- Hepatitis B, Chronic
- Entecavir (ETV)
- +2 more
-
Kolding, Denmark
- +29 more
Oct 27, 2022
Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])
Withdrawn
- Hepatitis B
- Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
-
Baltimore, Maryland
- +1 more
Jul 19, 2022
Cirrhosis, Liver, Vaccination Failure, HBV Trial (IMIQUIMOD cream, HEPATITIS B SURFACE ANTIGEN)
Not yet recruiting
- Cirrhosis, Liver
- +3 more
- IMIQUIMOD cream
- HEPATITIS B SURFACE ANTIGEN
- (no location specified)
Aug 27, 2021
Hepatitis B, Chronic Trial in Guangzhou (pegylated interferon-alfa)
Recruiting
- Hepatitis B, Chronic
- pegylated interferon-alfa
-
Guangzhou, Guangdong, ChinaDepartment of Infectious Diseases, The Third Affliated Hospital
Dec 20, 2021
Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir
Completed
- Chronic Hepatitis B
- Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Center
Mar 25, 2021
Chronic Hepatitis b Trial in Taipei (Spirulina)
Completed
- Chronic Hepatitis b
- Spirulina
-
Taipei, Wenshan District, TaiwanWanfang Hospital
Jan 20, 2021
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)
Active, not recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Edegem, Belgium
- +12 more
Jan 17, 2023
Hepatitis B Trial in Hanoi (Sci-B-Vac-Lot B, Sci-B-Vac-Lot A, Engerix-B)
Completed
- Hepatitis B
- Sci-B-Vac-Lot B
- +2 more
-
Hanoi, VietnamNational Institute of Hygiene and Epidemiology (NIHE)
Jul 18, 2022
After Long-Term Antiviral Treatment for Chronic Hepatitis B
Completed
- Chronic Hepatitis B e Antigen Positive
- Chronic Hepatitis B e Antigen Negative
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Chronic Hepatitis B Trial in Beijing (TCR-T)
Active, not recruiting
- Chronic Hepatitis B
- TCR-T
-
Beijing, ChinaThe Fifth Medical Center of PLA General Hospital
Jun 13, 2023
Chronic Hepatitis B Trial in Hong Kong (Treatment cessation)
Completed
- Chronic Hepatitis B
- Treatment cessation
-
Hong Kong, Hong KongDepartment of Medicine, The University of Hong Kong, Queen Mary
Feb 6, 2020
Chronic Hepatitis B Trial (Imdusiran (AB-729))
Not yet recruiting
- Chronic Hepatitis B
- Imdusiran (AB-729)
- (no location specified)
Nov 30, 2023
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)
Recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Vancouver, British Columbia, Canada
- +31 more
Jan 17, 2023
Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients
Recruiting
- AIDS
- Hepatitis B
- Peginterferon alfa-2b Injection
-
Guangzhou, Guangdong, ChinaGuangzhou Eighth People's Hospital, Guangzhou Medical University
Aug 10, 2023
Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)
Not yet recruiting
- Chronic Hepatitis B
- HRS9950 tablets
- HRS9950 placebo tablets
- (no location specified)
Jun 7, 2023
Hepatitis C, Chronic Trial (HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests, DAAs)
Completed
- Hepatitis C, Chronic
- HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests
- DAAs
- (no location specified)
Nov 22, 2019
Hepatitis B Vaccination Trial in Baltimore (Subcutaneous fat injection of Recombivax-HB, Intramuscular injection of
Completed
- Hepatitis B Vaccination
- Subcutaneous fat injection of Recombivax-HB
- Intramuscular injection of Recombivax-HB
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Nov 12, 2019
Chronic Hepatitis B Virus Trial in San Francisco (Stop NA therapy)
Active, not recruiting
- Chronic Hepatitis B Virus
- Stop NA therapy
-
San Francisco, California
- +1 more
Mar 29, 2021